Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2002 7
2003 3
2004 6
2005 6
2007 6
2008 2
2009 7
2010 4
2011 4
2012 4
2013 10
2014 8
2015 11
2016 7
2017 13
2018 11
2019 11
2020 9
2021 12
2022 9
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, Dalle S, Schenker M, Chiarion-Sileni V, Marquez-Rodas I, Grob JJ, Butler MO, Middleton MR, Maio M, Atkinson V, Queirolo P, Gonzalez R, Kudchadkar RR, Smylie M, Meyer N, Mortier L, Atkins MB, Long GV, Bhatia S, Lebbé C, Rutkowski P, Yokota K, Yamazaki N, Kim TM, de Pril V, Sabater J, Qureshi A, Larkin J, Ascierto PA; CheckMate 238 Collaborators. Weber J, et al. Among authors: yokota k. N Engl J Med. 2017 Nov 9;377(19):1824-1835. doi: 10.1056/NEJMoa1709030. Epub 2017 Sep 10. N Engl J Med. 2017. PMID: 28891423 Free article. Clinical Trial.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
Behçet's disease (Adamantiades-Behçet's disease).
Kaneko F, Togashi A, Saito S, Sakuma H, Oyama N, Nakamura K, Yokota K, Oguma K. Kaneko F, et al. Among authors: yokota k. Clin Dev Immunol. 2011;2011:681956. doi: 10.1155/2011/681956. Epub 2010 Nov 1. Clin Dev Immunol. 2011. PMID: 21052488 Free PMC article. Review.
Subcutaneous giant trichoblastoma in the abdomen.
Goto K, Kono M, Urata T, Hasegawa-Murakami Y, Matsumoto T, Yamashita Y, Yokota K, Akiyama M. Goto K, et al. Among authors: yokota k. J Dermatol. 2021 Aug;48(8):e393-e394. doi: 10.1111/1346-8138.15961. Epub 2021 May 8. J Dermatol. 2021. PMID: 33963593 No abstract available.
Chronic infections and atherosclerosis.
Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K. Ayada K, et al. Among authors: yokota k. Clin Rev Allergy Immunol. 2009 Aug;37(1):44-8. doi: 10.1007/s12016-008-8097-7. Clin Rev Allergy Immunol. 2009. PMID: 18985284 Review.
Chronic infections and atherosclerosis.
Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E, Oguma K. Ayada K, et al. Among authors: yokota k. Ann N Y Acad Sci. 2007 Jun;1108:594-602. doi: 10.1196/annals.1422.062. Ann N Y Acad Sci. 2007. PMID: 17894024 Review.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Puig S, Ascierto PA, Larkin J, Lorigan PC, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C, Eggermont AMM; EORTC Melanoma Group. Bottomley A, et al. Lancet Oncol. 2021 May;22(5):655-664. doi: 10.1016/S1470-2045(21)00081-4. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857414 Clinical Trial.
Use of ATP Bioluminescence Assay to Evaluate Oral Streptococci.
Watanabe A, Tamaki N, Yokota K, Kokeguchi S, Ito HO, Matsuyama M. Watanabe A, et al. Among authors: yokota k. Biocontrol Sci. 2022;27(4):229-233. doi: 10.4265/bio.27.229. Biocontrol Sci. 2022. PMID: 36567120 Free article.
Antibacterial Effects of Disulfiram in Helicobacter pylori.
Kobatake T, Ogino K, Sakae H, Gotoh K, Watanabe A, Matsushita O, Okada H, Yokota K. Kobatake T, et al. Among authors: yokota k. Infect Drug Resist. 2021 May 12;14:1757-1764. doi: 10.2147/IDR.S299177. eCollection 2021. Infect Drug Resist. 2021. PMID: 34012274 Free PMC article.
147 results